Vertex Pharmaceuticals Inc
VRTX
NASDAQ. Currency in USD
291.59 -13.21 ( -4.33% )
Market Cap.
74.85B
Beta (5Y monthly)
0.43
Price/Earnings
22.16
EPS (TTM)
14.50
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
1.65M
1y Target Est.
324.62
Day's Range
52 Week's Range
Historical Summary
Performance
1 Month
-7.32%
YTD
32.78%
1Y
35.91%
2Y
23.18%
10.99% ann.
3Y
33.89%
10.22% ann.
5Y
100.89%
14.97% ann.
10Y
577.80%
21.09% ann.
EPS growth
1Y
19.24%
2Y
52.47%
23.50% ann.
3Y
194.12%
43.27% ann.
5Y
763.10%
53.90% ann.
10Y
1,410.42%
31.20% ann.
20Y
1,350.00%
14.31% ann.
Share Buybacks
3 Months
-0.31%
6 Months
-0.62%
1Y
0.08%
2Y
1.73%
3Y
0.37%
5Y
-3.69%
10Y
-21.39%
20Y
-241.54%
About Vertex Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Website
https://www.vrtx.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
254.25M
Employees
3900
Address
50 Northern Avenue, Boston, MA, United States, 02210
Latest news
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
Upgrades
For NRG Energy Inc (NYSE:NRG), B of A Securities upgraded the previous rating of...
By Benzinga - 6 weeks ago

The Zacks Analyst Blog Highlights Merck, Vertex Pharmaceuticals, Immunocore Holdings and Immunovant
Merck, Vertex Pharmaceuticals, Immunocore Holdings and Immunovant are part of the Zacks top Analyst Blog.
By Zacks Investment Research - 6 weeks ago

Where Will Vertex Pharmaceuticals Be in 10 Years?
Expect a bigger, more diversified, and more entrenched entity to emerge over the coming years.
By The Motley Fool - 6 weeks ago

Buying These Unstoppable Stocks Before 2023 Could Be a Genius Move
These stocks have climbed by double digits this year.
By The Motley Fool - 6 weeks ago

Better Bear Market Buy: Vertex Pharmaceuticals vs. Biogen Stock
Both stocks are heading for double-digit gains this year.
By The Motley Fool - 6 weeks ago

My 3 Best Stocks of 2022 -- and Why I Think They'll Win Again in 2023
The momentum for these high-flying stocks should continue in the new year.
By The Motley Fool - 6 weeks ago

Should You Buy Stocks If a Recession Is Coming in 2023? Here's What History Shows.
Stocks usually go down during recessions, but long-term investors can still come out on top.
By The Motley Fool - 6 weeks ago

Which Is the Better Buy: Vertex or Invitae?
Is Vertex worth its lofty valuation compared to Invitae?
By The Motley Fool - 7 weeks ago